Kelso Pharma

Edinburgh-based specialty pharmaceuticals business Kelso Pharma has appointed former Big Four accountant and experienced pharmaceutical executive John Rooper as director of corporate development. With a wealth of experience in the life sciences sector after working at Ernst and Young (EY) in a senio

Edinburgh-headquartered pharmaceutical firm Kelso Pharma has expanded its portfolio with the acquisition of two UK approved dermatological products, marking its debut in the treatment of actinic keratoses and plaque psoriasis. The two dermatology products were purchased from an organisation within t

Kelso Pharma has appointed senior life sciences executive, Gordon Cameron, as its non-executive chairman. A senior executive with 25 years’ board-level experience in private equity and plc listed businesses, Mr Cameron has worked in the UK and US, primarily in biotech and pharmaceutical servic

Kelso Pharma has acquired Glasgow-based Stirling Anglian Pharmaceuticals Limited for an undisclosed sum. Kelso Pharma is headed by Dr Tom Stratford, previously CEO of Kyowa Kirin International, the European and US business arm of Kyowa Kirin, which purchased Scottish Borders based ProStrakan Group P